Do-Coop Drug Delivery Systems, Drug Development for the Pharma Industry

September 8, 2005: Do-Coop Technologies Announces Innovative New Product That Enhances Real Time PCR Sensitivity and Dynamic Range - Introduces Neowater - qPCR Enhancer to its Expanding Product Line

   

OR-YEHUDA, Israel, September 8 /PRNewswire/ -- Do-Coop Technologies Ltd., a privately held corporation based in Israel, announced today the commercial availability of its newest product, NeowaterTM - qPCR Enhancer, based on its proprietary NeowaterTM technology.

 
Do-Coop Technologies manufactures a stable system of largely hydrated nano-particles (NeowaterTM) for the Life Sciences. Among the recently introduced products we highlight NeowaterTM  - PCR Enhancer and NeowaterTM - Transfection Enhancer. Do-Coop's family of products, all based on Do-Coop's proprietary NeowaterTM  technology, dramatically enhances existing reagents, applications and processes to help segments of the Life Sciences industry to achieve the results they expect and need. Today.
 
About NeowaterTM
NeowaterTM -based products consist of a stable system of largely hydrated nano-particles that lead to several important benefits for research, diagnostics and bio-pharma applications. The hydrated nano-particles, like non-ionic detergent derived micelles, reduce the entropy of aqueous solutions and mimic intracellular water. In addition, by design, they exhibit hydrophobic properties. The non-ionic NeowaterTM  works by coating components at their molecular level, thus exposing, increasing and/or enhancing those specific surfaces which are required for a specific reaction but are normally not available to interact (e.g. GC-rich DNA). Therefore, very small volumes of NeowaterTM , and reduced component's concentrations or amounts, are needed for a reaction when using NeowaterTM . NeowaterTM  allows for (low-volume) miniaturization of Life Sciences products, applications and processes. NeowaterTM -based products significantly accelerate and improve the efficiency of biological reactions.
 
New Product Introduction: NeowaterTM  - qPCR Enhancer

NeowaterTM  - qPCR Enhancer has been especially formulated to enhance real-time PCR reactions in an incremental, non-disruptive yet highly effective way. In addition, NeowaterTM  - qPCR Enhancer allows for a significant increase in the qPCR reaction sensitivity, specificity, amplification efficiency and dynamic range, and has the ability to reliably detect rare target amplicons.

"We continue to add novel products that dramatically enhance upstream research and diagnostic processes. This new product, with validated third-party results, provides researchers with an easy yet effective way to enhance their real-time PCR reactions without the need to change equipment or protocols. All is required with our family of NeowaterTM  enhancer products is to pre-dilute the reaction's components in NeowaterTM  enhancer and proceed as usual. Our future plans include the introduction of novel downstream products such as protein expression and purification enhancers, as well as protein and enzyme stabilizers and diagnostic kit enhancers, all of which are based on NeowaterTM  technology," said Eran Gabbai, founder and CTO of Do-Coop Technologies, and the inventor of NeowaterTM .

Do-Coop Technologies will continue with its previously launched and highly successful free samples program to allow end-users to try the new product and verify the company's claims by using the provided sample and protocol within their own qPCR processes.

 

Drug development | Enzyme Stabilization | Protein Stabilization | PharmaPharmaceutical companies